We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Genzyme deal set to alter biotech landscape.
- Authors
Ledford, Heidi
- Abstract
The article presents information on the biotech company Genzyme Corp. which first started business in 1981 in Cambridge, Massachusetts. Today, it has 10,000 employees and 4 billion dollars in annual sales. Genzyme is about to start a new life as a branch of the pharmaceutical giant Sanofi-Aventis US LLC in 2011. This 20-billion dollars deal was announced on February 16, 2011. Alison Taunton-Rigby, a former senior vice-president at Genzyme, says that Genzyme is still more nimble than big pharma.
- Subjects
CAMBRIDGE (Mass.); MASSACHUSETTS; GENZYME Corp.; PHARMACEUTICAL industry; SANOFI-Aventis US LLC; TAUNTON-Rigby, Alison
- Publication
Nature, 2011, Vol 470, Issue 7335, p449
- ISSN
0028-0836
- Publication type
Article
- DOI
10.1038/470449a